Insider Selling: Oscar Health (NYSE:OSCR) CAO Sells $33,414.62 in Stock

Oscar Health, Inc. (NYSE:OSCR) CAO Victoria Baltrus sold 1,523 shares of the company’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $33,414.62. Following the completion of the transaction, the chief accounting officer owned 214,589 shares of the company’s stock, valued at $4,708,082.66. This trade represents a 0.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Price Performance

Shares of OSCR stock opened at $24.59 on Friday. The company has a market capitalization of $7.41 billion, a PE ratio of -41.68, a price-to-earnings-growth ratio of 1.71 and a beta of 2.37. The firm has a fifty day simple moving average of $18.39 and a 200-day simple moving average of $16.06. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $25.58.

Oscar Health (NYSE:OSCR) last announced its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.96. The business had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business’s quarterly revenue was up 52.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.92 earnings per share. Equities research analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Robert W. Baird upped their target price on shares of Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Raymond James Financial upgraded shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price for the company in a research note on Thursday, February 12th. Jefferies Financial Group upgraded shares of Oscar Health from an “underperform” rating to a “hold” rating and upped their target price for the company from $10.00 to $16.00 in a research note on Monday, April 20th. Barclays upped their price target on shares of Oscar Health from $21.00 to $30.00 and gave the company an “equal weight” rating in a report on Tuesday, May 26th. Finally, Wells Fargo & Company set a $20.00 price target on shares of Oscar Health and gave the company an “equal weight” rating in a report on Thursday. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Oscar Health has an average rating of “Hold” and an average target price of $20.22.

Institutional Trading of Oscar Health

A number of institutional investors and hedge funds have recently modified their holdings of OSCR. Thrive Capital Management LLC raised its holdings in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the period. Baird Financial Group Inc. acquired a new stake in shares of Oscar Health during the first quarter worth $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Oscar Health by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock worth $2,827,000 after purchasing an additional 8,879 shares during the period. Jones Financial Companies Lllp raised its holdings in shares of Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Oscar Health by 39.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company’s stock worth $6,169,000 after purchasing an additional 132,149 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.

More Oscar Health News

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Wells Fargo upgraded Oscar Health from “strong sell” to “hold”, easing bearish sentiment even though its $20 target remains below the current share price. Zacks.com
• Positive Sentiment: Oscar Health’s recent earnings showed a major EPS beat, which supports the stock’s fundamental story despite revenue coming in below estimates.
• Neutral Sentiment: A company co-founder shifting into an advisory leadership role looks like an internal reorganization rather than a disruptive change. Oscar Health Co-Founder Shifts to Advisory Leadership Role
• Neutral Sentiment: Multiple insiders, including CFO Richard Scott Blackley and CAO Victoria Baltrus, sold shares under pre-planned 10b5-1 programs to cover tax obligations on vested equity awards, which is less concerning than discretionary selling.
• Negative Sentiment: Director Mario Schlosser sold 34,120 shares, the largest insider sale in the latest batch, which may pressure sentiment even though it was pre-arranged.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.